Financhill
Sell
37

NGVT Quote, Financials, Valuation and Earnings

Last price:
$47.20
Seasonality move :
-2.64%
Day range:
$45.99 - $47.72
52-week range:
$30.90 - $56.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
8.00x
Volume:
282.1K
Avg. volume:
244.5K
1-year change:
17.88%
Market cap:
$1.7B
Revenue:
$1.7B
EPS (TTM):
-$15.53

Analysts' Opinion

  • Consensus Rating
    Ingevity has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $54.25, Ingevity has an estimated upside of 14.94% from its current price of $47.20.
  • Price Target Downside
    According to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $47.20.

Fair Value

  • According to the consensus of 3 analysts, Ingevity has 14.94% upside to fair value with a price target of $54.25 per share.

NGVT vs. S&P 500

  • Over the past 5 trading days, Ingevity has overperformed the S&P 500 by 20.7% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Ingevity does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Ingevity revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Ingevity reported revenues of $376.9M.

Earnings Growth

  • Ingevity earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Ingevity reported earnings per share of -$2.95.
Enterprise value:
3.1B
EV / Invested capital:
--
Price / LTM sales:
1.16x
EV / EBIT:
--
EV / Revenue:
2.08x
PEG ratio (5yr expected):
--
EV / Free cash flow:
108.40x
Price / Operating cash flow:
60.32x
Enterprise value / EBITDA:
46.21x
Gross Profit (TTM):
$412.3M
Return On Assets:
-22.65%
Net Income Margin (TTM):
-38.11%
Return On Equity:
-116.58%
Return On Invested Capital:
-28.61%
Operating Margin:
22.42%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $1.6B $1.7B $1.5B $446M $376.9M
Gross Profit $569.7M $517.8M $412.3M $129M $129.9M
Operating Income $348.4M $289.8M $213.6M $81.2M $84.5M
EBITDA $450M $370.4M -$486.2M $86.5M -$86.8M
Diluted EPS $5.81 $3.42 -$15.53 $0.69 -$2.95
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $601M $720.3M $645.1M $734.5M $636.8M
Total Assets $2.3B $2.4B $2.3B $2.8B $2.2B
Current Liabilities $178.9M $247.6M $290.3M $305.1M $360.8M
Total Liabilities $1.6B $1.8B $1.7B $2B $2B
Total Equity $617M $644.5M $633.9M $718.7M $214.5M
Total Debt $1.3B $1.3B $1.2B $1.5B $1.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $291.2M $257.4M $110.3M $105.2M $46.5M
Cash From Investing -$199.9M -$459.8M -$76.2M -$32.3M -$17.4M
Cash From Financing -$277.7M $219.6M $20.9M -$53.3M -$6.3M
Free Cash Flow $160.5M $127.6M $28.4M $71.7M $28.5M
NGVT
Sector
Market Cap
$1.7B
$18.9M
Price % of 52-Week High
83.84%
60.61%
Dividend Yield
0%
0%
Shareholder Yield
0.4%
1.57%
1-Year Price Total Return
17.88%
-12.81%
Beta (5-Year)
1.650
1.044
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $41.20
200-day SMA
Buy
Level $43.12
Bollinger Bands (100)
Buy
Level 35.82 - 45.56
Chaikin Money Flow
Sell
Level -6M
20-day SMA
Buy
Level $40.88
Relative Strength Index (RSI14)
Buy
Level 67.49
ADX Line
Buy
Level 31.38
Williams %R
Sell
Level -4.4919
50-day SMA
Buy
Level $44.38
MACD (12, 26)
Sell
Level -0.09
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 11M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.9352)
Sell
CA Score (Annual)
Level (-1.2341)
Buy
Beneish M-Score (Annual)
Level (-2.9195)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-19.3105)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Stock Forecast FAQ

In the current month, NGVT has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NGVT average analyst price target in the past 3 months is $54.25.

  • Where Will Ingevity Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Ingevity share price will rise to $54.25 per share over the next 12 months.

  • What Do Analysts Say About Ingevity?

    Analysts are divided on their view about Ingevity share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ingevity is a Sell and believe this share price will drop from its current level to $45.00.

  • What Is Ingevity's Price Target?

    The price target for Ingevity over the next 1-year time period is forecast to be $54.25 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is NGVT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Ingevity is a Hold. 2 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of NGVT?

    You can purchase shares of Ingevity via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ingevity shares.

  • What Is The Ingevity Share Price Today?

    Ingevity was last trading at $47.20 per share. This represents the most recent stock quote for Ingevity. Yesterday, Ingevity closed at $47.20 per share.

  • How To Buy Ingevity Stock Online?

    In order to purchase Ingevity stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Trump Presidency Means For Stock Market
What Trump Presidency Means For Stock Market

Donald Trump was the first president in modern U.S. history…

Where Will TJX Companies Stock Be in 10 Years?
Where Will TJX Companies Stock Be in 10 Years?

Off-price retail is as popular as ever thanks to social…

Will CVS Health Stock Recover?
Will CVS Health Stock Recover?

It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
45
QMCO alert for Jan 16

Quantum [QMCO] is down 0% over the past day.

Buy
51
QRVO alert for Jan 16

Qorvo [QRVO] is down 0% over the past day.

Sell
31
ATEX alert for Jan 16

Anterix [ATEX] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock